Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Javier Cortes Sandra M. Swain Eva M Ciruelos Vladimir Semiglazov |
| Publication date | April 18, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |